Meaningful Use Objectives for Stage 2-3

Embed Size (px)

Citation preview

  • 8/8/2019 Meaningful Use Objectives for Stage 2-3

    1/3

    Overview of Meaningful Use Objecctive

    Stage 1 Final Rule

    Key:

    Improving Quality, Safety, Efficiency & Reducing Health Dis

    CPOE for all orders

    Use evidence-based order sets

    Drug-drug/drug-allergy interaction checks

    Report CQM electronically*

    Implement 1 CDS rule*Implement drug formulary checks

    Record advance directives (EP)

    Generate patient registry lists*

    Document progress note (EP)

    Record family historyUse patient-specific care plans

    CMS Signal for Stage 2

    HITPC Aug '09 Stage 2 (or Staincluded)

    Astrick (*) indicates an objective that potentially could be retired in future MU stage because it would be presumed with a higher-order objective. Whmeasure is put on the same row as a Stage 1 measure that could be retired with introduction of the new.Italics

    indicates optional measure for Stage 1 (CMS signaled core for Stage 2)

    CPOE for Rx orders* (30%)

    E-prescribing (EP) (40%)E-prescribing discharge prescrip(EH)

    Record demographics* (50%)Stratified electronic CQM rep

    disparity variables

    Stratified electronic CQM repdisparity variables

    Maintain problem list* (80%)Maintain active med list* (80%)Maintain active med-allergy list* (80%)Record vital signs* (50%)Record smoking status* (50%)

    Use CDS at point of care (e.g., ralerts)

    Record advance directives (EH) (50%)

    Incorporate lab results as structured data (40%)

    Manage chronic conditions usinregistry lists

    Send patient reminders (20%)Electronic insuranceeligibilityElectronic claimssubmission

    Record all clinical documentatio(EH)

    Specialists report to external disregistries

    Conduct closed loop medicationmanagement (EH)

  • 8/8/2019 Meaningful Use Objectives for Stage 2-3

    2/3

    Overview of Meaningful Use Objecctive

    Stage 1 Final Rule

    Key:

    CMS Signal for Stage 2

    HITPC Aug '09 Stage 2 (or Staincluded)

    Astrick (*) indicates an objective that potentially could be retired in future MU stage because it would be presumed with a higher-order objective. Wmeasure is put on the same row as a Stage 1 measure that could be retired with introduction of the new.Italics

    indicates optional measure for Stage 1 (CMS signaled core for Stage 2)

    Engage Patients and Families in Their Care

    Provide timely electronic access

    Patient-provider secure messagi

    Improve Care Coordination

    Perform test of HIE*

    Retrieve and act on eRx data

    Provide electronic copy of health information* (50%)

    Provide electronic copy of discharge instructions (EH) at discharge (50%)

    Provide clinical summaries each office visit (EP)* (50%)

    Provide timely electronic access (EP)* (10%)

    EHR-enabled patient-specific educational resources* (10%)Patient-specific eduation resourcmany languages

    Record patient preferences (e.g.,communication media, proxies, options)

    Incorporate patient-generated dadevices)

    Robust exchange of data

    Perform medication reconciliation* (50%)Perform medication reconciliaticare transition

    Provide summary of care record* (50%)Produce & share summary care revery care transition

  • 8/8/2019 Meaningful Use Objectives for Stage 2-3

    3/3

    Overview of Meaningful Use Objecctives

    Stage 1 Final Rule

    Key:

    CMS Signal for Stage 2

    HITPC Aug '09 Stage 2 (or Stageincluded)

    Astrick (*) indicates an objective that potentially could be retired in future MU stage because it would be presumed with a higher-order objective. Whmeasure is put on the same row as a Stage 1 measure that could be retired with introduction of the new.Italics indicates optional measure for Stage 1 (CMS signaled core for Stage 2)

    Improve Population and Public Health

    Submit immunization data* Bidirectional immunization dataSubmit reportable lab data

    Submit surveillance data Bidirectional surveillance data

    Ensure Adequate Privacy and Security Protections for Personal Health Inf

    Conduct security review analysis & correct deficiencies

    Other Issues:

    Use summarized/de-identified datapopulation health purposes

    18 month EHR vendor dilemma4 options:o 90-day utilization/12-month QMo 90-day reporting periodo Certified product in middleo Certified product at end